Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis

JCI Insight. 2019 Mar 21;4(6):e126599. doi: 10.1172/jci.insight.126599.

Abstract

B cells are key contributors to chronic autoimmune pathology in multiple sclerosis (MS). Clonally related B cells exist in the cerebrospinal fluid (CSF), meninges, and CNS parenchyma of MS patients. We sought to investigate the presence of clonally related B cells over time by performing Ig heavy chain variable region repertoire sequencing on B cells from longitudinally collected blood and CSF samples of MS patients (n = 10). All patients were untreated at the time of the initial sampling; the majority (n = 7) were treated with immune-modulating therapies 1.2 (±0.3 SD) years later during the second sampling. We found clonal persistence of B cells in the CSF of 5 patients; these B cells were frequently Ig class-switched and CD27+. Specific blood B cell subsets appear to provide input into CNS repertoires over time. We demonstrate complex patterns of clonal B cell persistence in CSF and blood, even in patients on immune-modulating therapy. Our findings support the concept that peripheral B cell activation and CNS-compartmentalized immune mechanisms can in part be therapy resistant.

Keywords: B cell receptor; B cells; Immunology; Multiple sclerosis; Neuroscience.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B-Lymphocyte Subsets / immunology
  • B-Lymphocytes / immunology*
  • Cerebrospinal Fluid / immunology*
  • Female
  • Humans
  • Immunoglobulin Variable Region
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / cerebrospinal fluid*
  • Multiple Sclerosis / immunology*
  • Young Adult

Substances

  • Immunoglobulin Variable Region